Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand

被引：0
|
作者：
Unchalee Permsuwan
Nathorn Chaiyakunapruk
Piyameth Dilokthornsakul
Kednapa Thavorn
Surasak Saokaew
机构：
[1] Chiang Mai University,Faculty of Pharmacy
[2] School of Pharmacy,Center of Pharmaceutical Outcomes Research (CPOR), Faculty of Pharmaceutical Sciences
[3] Monash University Malaysia,Faculty of Medicine
[4] Naresuan University,School of Pharmaceutical Sciences, Center of Health Outcomes Research and Therapeutic Safety (COHORTS)
[5] School of Population Health,undefined
[6] University of Queensland,undefined
[7] School of Pharmacy,undefined
[8] University of Wisconsin-Madison,undefined
[9] Ottawa Hospital Research Institute,undefined
[10] The Ottawa Hospital,undefined
[11] School of Epidemiology,undefined
[12] Public Health and Preventive Medicine,undefined
[13] University of Ottawa,undefined
[14] Institute of Clinical and Evaluative Sciences,undefined
[15] University of Phayao,undefined
来源：
Applied Health Economics and Health Policy | 2016年 / 14卷
关键词：
Insulin Glargine; Weighted Mean Difference; Thai Population; Social Security Scheme; CORE Diabetes Model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 292
页数：11
相关论文
共 50 条
  • [21] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    [J]. DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [22] Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine Hagedorn insulin in patients with type 2 diabetes
    Linn, Thomas
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemens
    Bretzel, Reinhard G.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (10): : 3839 - 3846
  • [23] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    [J]. Diabetes Therapy, 2015, 6 : 593 - 610
  • [24] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    [J]. JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [25] LONG-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NEUTRAL PROTAMINE HAGEDORN INSULIN IN PATIENTS WITH TYPE I DIABETES USING A BASAL-BOLUS REGIMEN IN BELGIUM, FRANCE, GERMANY, ITALY AND SPAIN
    Gschwend, M. H.
    Aagren, M.
    Valentine, W. J.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A501 - A502
  • [26] Comparison of Incidence of Acute Myocardial Infarction in Patients With Type 2 Diabetes Mellitus Following Initiation of Neutral Protamine Hagedorn Insulin Versus Insulin Glargine
    Rhoads, George G.
    Kosiborod, Mikhail
    Nesto, Richard W.
    Fonseca, Vivian A.
    Lu, Shou-En
    Zhang, Quanwu
    Foody, Joanne M.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (07): : 910 - 916
  • [27] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Xu, J.
    Lan, K.
    Wang, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [28] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Insulin-naive Chinese Patients With Type 2 Diabetes
    Cheng, Huafeng
    Wan, Xu
    Ma, Jing
    Wu, Bin
    [J]. CLINICAL THERAPEUTICS, 2019, 41 (03) : 445 - 455
  • [29] COST-EFFECTIVENESS ANALYSIS OF INSULIN DEGLUDEC/INSULIN ASPART VERSUS INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES IN CHINA
    Liu, C.
    Tao, L. B.
    Wang, F.
    [J]. VALUE IN HEALTH, 2020, 23 : S111 - S111
  • [30] Two-year glycaemic control and healthcare expenditures following initiation of insulin glargine versus neutral protamine Hagedorn insulin in type 2 diabetes
    Rhoads, G. G.
    Dain, M. P.
    Zhang, Q.
    Kennedy, L.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (08): : 711 - 717
12345